327 related articles for article (PubMed ID: 32912056)
21. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.
Green BB; Coronado GD; Schwartz M; Coury J; Baldwin LM
Implement Sci; 2019 May; 14(1):53. PubMed ID: 31142348
[TBL] [Abstract][Full Text] [Related]
22. Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial.
Kapinos KA; Halm EA; Murphy CC; Santini NO; Loewen AC; Skinner CS; Singal AG
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2383-2392.e4. PubMed ID: 35144024
[TBL] [Abstract][Full Text] [Related]
23. Colorectal Cancer Screening and Yield in a Mailed Outreach Program in a Safety-Net Healthcare System.
Murphy CC; Halm EA; Zaki T; Johnson C; Yekkaluri S; Quirk L; Singal AG
Dig Dis Sci; 2022 Sep; 67(9):4403-4409. PubMed ID: 34800219
[TBL] [Abstract][Full Text] [Related]
24. Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.
Elangovan A; Skeans J; Lalani I; Ullah F; Roy A; Kaelber DC; Cooper GS; Sandhu DS
Dig Dis Sci; 2021 Aug; 66(8):2585-2594. PubMed ID: 32816217
[TBL] [Abstract][Full Text] [Related]
25. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
[TBL] [Abstract][Full Text] [Related]
26. Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population.
Karlitz JJ; Fendrick AM; Bhatt J; Coronado GD; Jeyakumar S; Smith NJ; Plescia M; Brooks D; Limburg P; Lieberman D
Popul Health Manag; 2022 Jun; 25(3):343-351. PubMed ID: 34958279
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
[TBL] [Abstract][Full Text] [Related]
28. Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members.
Meenan RT; Baldwin LM; Coronado GD; Schwartz M; Coury J; Petrik AF; West II; Green BB
Popul Health Manag; 2021 Apr; 24(2):255-265. PubMed ID: 32609077
[TBL] [Abstract][Full Text] [Related]
29. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
30. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
[TBL] [Abstract][Full Text] [Related]
31. Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.
Coury JK; Schneider JL; Green BB; Baldwin LM; Petrik AF; Rivelli JS; Schwartz MR; Coronado GD
Transl Behav Med; 2020 Feb; 10(1):68-77. PubMed ID: 30445511
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Colorectal Cancer Screening Modality Among Newly Age-Eligible Medicaid Enrollees.
Mojica CM; Lind B; Gu Y; Coronado GD; Davis MM
Am J Prev Med; 2021 Jan; 60(1):72-79. PubMed ID: 33223363
[TBL] [Abstract][Full Text] [Related]
33. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
[TBL] [Abstract][Full Text] [Related]
34. Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial.
Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Kimbel KJ; Kullgren JT; Meenan RT; Vernon SW
JAMA Netw Open; 2019 Jul; 2(7):e196570. PubMed ID: 31276178
[TBL] [Abstract][Full Text] [Related]
35. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
36. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Levin TR; Jensen CD; Chawla NM; Sakoda LC; Lee JK; Zhao WK; Landau MA; Herm A; Eby E; Quesenberry CP; Corley DA
Gastroenterology; 2020 Nov; 159(5):1695-1704.e1. PubMed ID: 32702368
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of a mailed fecal immunochemical test outreach: a Medicare Advantage pilot study.
Issaka RB; Akinsoto NO; Strait E; Chaudhari V; Flum DR; Inadomi JM
Therap Adv Gastroenterol; 2020; 13():1756284820945388. PubMed ID: 32952612
[TBL] [Abstract][Full Text] [Related]
38. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
[TBL] [Abstract][Full Text] [Related]
39. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
[TBL] [Abstract][Full Text] [Related]
40. Comparative cost-effectiveness of mailed fecal immunochemical testing (FIT)-based interventions for increasing colorectal cancer screening in the Medicaid population.
Wheeler SB; O'Leary MC; Rhode J; Yang JY; Drechsel R; Plescia M; Reuland DS; Brenner AT
Cancer; 2020 Sep; 126(18):4197-4208. PubMed ID: 32686116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
